Metamitron

CAS No. 41394-05-2

Metamitron ( —— )

Catalog No. M28310 CAS No. 41394-05-2

Metamitron is a photosynthetic electron transport chain inhibitor and can be used as a chemical thinner.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 45 Get Quote
10MG 63 Get Quote
25MG 103 Get Quote
50MG 150 Get Quote
100MG 223 Get Quote
500MG 482 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Metamitron
  • Note
    Research use only, not for human use.
  • Brief Description
    Metamitron is a photosynthetic electron transport chain inhibitor and can be used as a chemical thinner.
  • Description
    Metamitron is a photosynthetic electron transport chain inhibitor and can be used as a chemical thinner.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Human Endogenous Metabolite
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    41394-05-2
  • Formula Weight
    202.2
  • Molecular Formula
    C10H10N4O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1C(=NN=C(N1N)C)C=2C=CC=CC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Fringuelli R, et al. Synthesis and evaluation of anti-apoptotic activity of L-carnitine cyclic analogues and amino acid derivatives. Farmaco. 2004 Apr;59(4):271-7.
molnova catalog
related products
  • Alpinumisoflavone

    Alpinumisoflavone has atheroprotective effects, may result from their ability to upregulate mechanisms promoting HDL-cholesterol and bile acid formation, it is endowed with estrogenic properties accounting, at least in part, for E. lysistemon effects.

  • (Rac)-5-Keto Fluvast...

    (Rac)-5-Keto Fluvastatin is an impurity of Fluvastatin. Fluvastatin is an inhibitor of HMG-CoA reductase(IC50 of 8 nM).

  • L-822179

    L-822179 (α5IA) is a selective inverse agonist for the Α5 subtype of GABAA receptor with higher intrinsic activity at the A5 subtype than other drugs.